Advaxis logo

ADXS Advaxis

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.

Healthcare Biotechnology SIC: Unknown CIK: 1100397 Auditor raised Going Concern issues

Login to follow ADXS

Transaction DateRecipientSharesTypePriceValue
Jodie Insights Rating